Data Insights
Artificial Intelligence (9)
Big Data (3)
Biosimilars (5)
Blockchain (1)
Cell & Gene Therapy (12)
Chemotherapy (1)
Cloud (1)
Corporate Governance (2)
Covid-19 (5)
Cybersecurity (3)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (2)
Environmental Sustainability (5)
Future of Work (2)
Genomics (10)
Health & Wellness (1)
Immuno-oncology (19)
Immunotherapy (1)
Individualism & Expression (1)
Internet of Things (2)
Microbiome (1)
Mobile Health (1)
Nanomedicine (2)
Oncology (4)
Orphan Designated Drugs (4)
Other Innovation Areas (87)
Personalization (1)
Precision and Personalized Medicine (1)
Remote Patient Monitoring (1)
Renewable Energy (1)
Robotics (2)
Small molecules (1)
Smart Hospitals (2)
Social Responsibility (3)
Virtual Care (2)
Showing 2 results out of 2
Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that electronic medical record (emr) systems accounted for 2...
Q4 2023 update: electronic medical record (emr) systems related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that electronic medical record (emr) systems accounted for 2 pharmaceutical deals...